A Game-Based Learning Experience on Modern Approaches in the Management of Chronic Heart Failure
Chronic heart failure (HF) has become a disease epidemic, with rising incidence and mortality rates. Symptoms and signs of HF are caused by systolic or diastolic dysfunction and can include dyspnea, edema, rales, neck vein distention, cough, tachycardia, chest pain/pressure and fatigue. These can significantly impact the patient’s ability to deal with activities of daily living.
Acute exacerbations are the most common reason for hospitalizations of HF patients and present the most common reason for inpatient treatment in persons aged 65 and over. Evidence suggests that rates of HF-related hospitalizations and mortality can be improved with carefully-selected therapy and an emphasis on patient self-care. As pharmacologic treatment options continue to expand, it is critical that clinicians have the most recent data regarding the pathophysiology, risk factors and treatment of HF in order to optimize patient management and outcomes.
This educational activity features a self-directed learning experience focused on the latest information on HF treatment. This activity is designed to be interactive and will guide you through sets of game-based questions presented in the form of answers. Multiple choice options will be provided in the form of questions, and you will be asked to choose the best question for each answer.
To begin the activity, please click the button below.
Note: You may need to adjust the zoom on your webpage for an optimal view of the activity.
CME Released: December 22, 2017
Valid for Credit Through: December 22, 2018
Time to Complete: 1 hour
Upon completion of this educational activity, participants should be able to:
Describe the epidemiology, risk factors and pathophysiology of HF
Describe clinical data on new and emerging treatments for HF
Define appropriate patient selection for application of new HF therapies
Identify barriers to poor treatment adherence and strategies to improve adherence
The target audience for this activity is cardiologists, internists, primary care physicians, hospitalists, intensivists, advanced practice nurses, PAs, nurses and other healthcare professionals who actively manage patients with chronic heart failure.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Warren Alpert Medical School of Brown University and Catamount Medical Education. The Alpert Medical School is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Warren Alpert Medical School of Brown University designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Akshay Suvas Desai, MD, MPH
Director, Cardiomyopathy and Heart Failure Program
Brigham and Women’s Hospital
Associate Professor of Medicine
Harvard Medical School
This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation.
Requirements for Successful Completion
In order to receive credit, participants must answer the questions in the activity, view the activity presentations and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test with a passing score of ≥ 78%, and evaluation form.
Faculty and Disclosure/Conflict of Interest Policy
In accordance with ACCME requirements, the Warren Alpert Medical School of Brown University has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.
Dr. Desai discloses the following relationships:
Grant/Research Support: Novartis
Consultant: Abbott, AstraZeneca, DalCor Pharma, Novartis, Relypsa
Planners and Independent Reviewers
The following report no financial interests/relationships or affiliations in relation to this activity:
Warren Alpert Medical School of Brown University
Susan Denner, MD, MS
Catamount Medical Education
Chief Learning Officer
Catamount Medical Education
The Office of Continuing Medical Education (CME) and its educational partners protect the privacy of personal and other information regarding participants & educational collaborators. The CME Office maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. The CME Office will keep your personal information confidential when you participate in a CME Internet-based program. The CME Office collects only the information necessary to provide you with the services that you request.
This educational program is designed to present scientific information and opinion to health professionals, to stimulate thought, and further investigation.
To access these activities, users will need:
A computer with an Internet connection.
The most recent version of Microsoft Chrome, Internet Explorer, Firefox, Safari, or any other W3C standards compliant browser.
For optimum results we recommend a device that has a display capability of 1920 x 1080 or better. Mobile devices are not recommended for this activity.
For questions regarding this activity, please contact Catamount Medical Education: 860-661-4164 or email@example.com.
Please note, once you have completed viewing this page, don’t forget to click on the “Begin Activity” button above. You will not be able to begin the activity until you do so.
This CME activity is jointly provided by the Warren Alpert Medical School of Brown University and Catamount Medical Education.